Hi there,

If you think Democracy Now!’s reporting is a critical line of defense against war, climate catastrophe and authoritarianism, please make your donation of $10 or more right now. Today, a generous donor will DOUBLE your donation, which means it’ll go 2x as far to support our independent journalism. Democracy Now! is funded by you, and that’s why we’re counting on your donation to keep us going strong. Please give today. Every dollar makes a difference—in fact, gets doubled! Thank you so much.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

Pfizer Vaccine Could Be Made Available to U.S. Children Under 5 by March

HeadlineFeb 01, 2022

The number of daily coronavirus infections reported around the United States continues to fall rapidly from mid-January’s peak but remains higher than at any other point in the pandemic. More than 2,500 people are dying of COVID-19 each day, with the official U.S. death toll on pace to pass 900,000 in mid-February.

Pfizer is preparing to request emergency use authorization for its vaccine in children aged 6 months to 5 years old. That’s according to The Washington Post, which reports the request by Pfizer and its partner BioNTech could come far sooner than expected, and a decision by health regulators could come as early as the end of February.

Meanwhile, the Food and Drug Administration has fully authorized Moderna’s COVID-19 vaccine for use in U.S. adults. It’s the second vaccine to get full FDA approval, after Pfizer’s mRNA vaccine won full authorization last August.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top